Clinical Registry on Treatment Reality and Sequential Treatments of Patients with Resectable or Locally Advanced/metastatic Pancreatic Cancer in Real-life Practice in Germany
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- iOMEDICO AG
- 入组人数
- 2,325
- 试验地点
- 1
- 主要终点
- Treatment reality in Germany
研究概览
简要总结
The registry aims to collect and analyse information on the antineoplastic treatment of patients with unresectable locally advanced or metastatic pancreatic cancer, treated in palliative intention (cohort 1) and patients with localized, resectable pancreatic cancer treated in neo-adjuvant or adjuvant intention (cohort 2) in daily routine practice in Germany. The registry will follow up patients for two years. It will identify common sequences of treatments used as well as changes in the treatment of the disease. Health-related quality of life will be analysed during the course of the treatment (PanLife). Based on the available data a prognostic score will be developed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •resectable or locally advanced/metastatic pancreatic cancer
- •18 years and older
- •Antineoplastic treatment
- •Date of consent no later than 2 weeks after start of first-line treatment
排除标准
- •No pancreatic cancer
- •Below 18 years and older
- •No antineoplastic treatment
- •Date of consent later than 2 weeks after start of first-line treatment
结局指标
主要结局
Treatment reality in Germany
时间窗: over 5 years
description of treatments selected for patients per line of therapy over the course of the project
次要结局
未报告次要终点